《依降钙素联合弥可保治疗腰椎管狭窄症的研究》为作者：冀东兴最新的研究成果，本论文的主要观点为目的：观察依降钙素联合弥可保治疗腰椎管狭窄症的有效性和安全性。 方法：将2016年4月至2017年9月本科就诊的腰椎管狭窄症患者按就诊顺序随机分为两组：治疗组(71例)同时给予依降钙素、弥可保、扶他林三种药物；对照组(56例)单纯予以扶他林。对所有患者均进行3月的随访。采用视觉模拟疼痛评分(Visual Analogue Scale, VAS)、日本骨科学会评分(Japanese Orthopaedic Association,JOA)对纳入患者进行评估。定期对患者进行随访，记录相关测量数据。 结果：治疗组患者在2周、3月时间点上在VAS评分、JOA评分均优于观察组，差异有统计学意义(P＜0。05）。 结论：应用依降钙素联合弥可保治疗腰椎管狭窄症安全有效。 关键词:依降钙素；弥可保；腰椎管狭窄症 Summary OBJECTIVE: To observe the efficacy and safety of Elcatonin combined with Methycobal in the treatment of lumbar spinal stenosis。 METHODS: Patients with lumbar spinal stenosis who underwent undergraduate treatment from April 2016 to September 2017 were randomly divided into two groups according to the order of treatment: the treatment group (71 cases) were given three drugs: Elcatonin, Methycobal, and voltaren。 The control group (56 cases) was given only to voltaren。 All patients were followed for 3 months。 Patients were included for evaluation using the Visual Analogue Scale (VAS) and the Japanese Orthopaedic Association (JOA)。 Patients were followed up regularly and relevant measurement data were recorded。 RESULTS:The VAS score and JOA score were better in the treatment group than in the observation group at 2 weeks and 3 months, and the difference was statistically significant (P<0。05)。 Conclusion: The use of Elcatonin combined with Methycobal is safe and effective in the treatment of lumbar spinal stenosis。 Key words：Elcatonin; Methycobal; Lumbar spinal stenosis。现欲投《中国中西医结合杂志》，不知是否符合录用要求，望您批评与指正。